Suppr超能文献

肾移植进展。一项针对3359例患者长达25年的单中心研究。

Progress in renal transplantation. A single center study of 3359 patients over 25 years.

作者信息

Diethelm A G, Deierhoi M H, Hudson S L, Laskow D A, Julian B A, Gaston R S, Bynon J S, Curtis J J

机构信息

Department of Surgery, University of Alabama School of Medicine, Birmingham, USA.

出版信息

Ann Surg. 1995 May;221(5):446-57; discussion 457-8. doi: 10.1097/00000658-199505000-00002.

Abstract

OBJECTIVE

The study analyzed 3359 consecutive renal transplant operations for patient and graft survival, including living related, cadaveric, and living unrelated patients. The analysis was separated into three groups according to immunosuppression and date of transplant.

SUMMARY BACKGROUND DATA

Improvements in renal transplantation in the past 25 years have been the result of better immunosuppression, organ preservation, and patient selection.

METHODS

A single transplant center's experience over a 25-year period was analyzed regarding patient and graft survival. Potential risk factors included patient demographics, tissue typing, donor characteristics, number of transplants, acute and chronic rejection, acute tubular necrosis, primary disease, and malignancy.

RESULTS

The primary cause of graft loss was rejection. Improvement in cadaveric graft survival since 1987 with quadruple therapy was not apparent in living donor patients. Race continued to be a negative factor in graft survival. Avoiding previous mismatched antigens and the use of flow cytometry improved allograft survival. The leading cause of death in the past 7 years in cadaveric recipients was cardiac (52%).

CONCLUSIONS

Improved graft survival in the past 25 years was related to 1) advances in immunosuppression, 2) better methods of cytotoxic antibody detection, and 3) human lymphocyte antigen match.

摘要

目的

本研究分析了连续3359例肾移植手术患者的存活情况及移植物存活情况,包括亲属活体供肾、尸体供肾和非亲属活体供肾患者。根据免疫抑制情况和移植日期将分析分为三组。

总结背景数据

过去25年肾移植的改善得益于更好的免疫抑制、器官保存和患者选择。

方法

分析了一个移植中心25年间患者和移植物存活情况的经验。潜在风险因素包括患者人口统计学特征、组织配型、供体特征、移植次数、急慢性排斥反应、急性肾小管坏死、原发疾病和恶性肿瘤。

结果

移植物丢失的主要原因是排斥反应。自1987年以来,四联疗法在尸体供肾患者中未明显改善移植物存活情况。种族仍然是移植物存活的负面因素。避免既往不匹配抗原并使用流式细胞术可提高同种异体移植物存活。过去7年尸体供肾受者的主要死亡原因是心脏疾病(52%)。

结论

过去25年移植物存活情况的改善与以下因素有关:1)免疫抑制的进展;2)更好的细胞毒性抗体检测方法;3)人类淋巴细胞抗原匹配。

相似文献

8
The impact of 1,000 renal transplants at one center.一个中心1000例肾移植的影响。
Ann Surg. 1977 Oct;186(4):424-35. doi: 10.1097/00000658-197710000-00004.

引用本文的文献

5
Hepatitis B virus infection and renal transplantation.乙型肝炎病毒感染与肾移植。
World J Gastroenterol. 2010 Aug 21;16(31):3878-87. doi: 10.3748/wjg.v16.i31.3878.
10
Intestinal retransplantation.肠道再次移植
Transplant Proc. 1996 Oct;28(5):2773-4.

本文引用的文献

9
Chronic allograft rejection.慢性移植物排斥反应。
Immunol Rev. 1993 Aug;134:33-81. doi: 10.1111/j.1600-065x.1993.tb00639.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验